Investing in most current Alzheimer's drug companies is not recommended because they are not likely to modify the disease.

When it comes to treating degenerative diseases like Alzheimer’s, much of the current focus is on addressing the symptoms ...

CHICAGO, Nov 20 (Reuters) - Breakthrough Alzheimer’s treatments that remove toxic proteins from the brain have revived interest in vaccines to treat the memory-robbing disease, potentially ...

FDA approves much-debated Alzheimer’s drug panned by experts June 8, 2021 Alzheimer’s drug from Eisai and Biogen slows cognitive decline, side-effects in focus ...

Citation: New Alzheimer's drug shines light on need for assessments to head off 'a tsunami of cognitive afflictions' (2023, November 20) retrieved 5 December 2023 from https://medicalxpress.com ...

Anavex's Alzheimer's drug Blarcamesine demonstrates strong statistical significance in improving cognition among dementia patients as measured by one co-primary endpoint and one secondary endpoint.

Dec. 8, 2023 — Researchers have identified an enzyme that blocks insulin produced in the body -- a discovery that could provide a new target to treat diabetes. The study focuses on nitric oxide ...

This study tried to detect any molecular substrate that might be shared by brain disorders in general, comparing gene expression profiles across multiple brain areas determined by post-mortem ...

Nov. 20—(StatePoint) 2023 was a landmark year for Alzheimer's disease research, including advancements in treatment, risk factors and diagnosis. Here are five significant discoveries made this year: ...

CHICAGO, Nov 20 (Reuters) - Breakthrough Alzheimer’s treatments that remove toxic proteins from the brain have revived interest in vaccines to treat the memory-robbing disease, potentially ...